mim 4D5.1 (Xcyte)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemim 4D5.1 (Xcyte)
Drug Alias Namemim 4D5.1 (CDR Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsProstatic Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCyclacel Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCyclacel Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursUrinary Bladder NeoplasmsProstatic Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A